Here are three stocks with buy rank and strong momentum characteristics for investors to consider today, January 8th:
Akoya Biosciences, Inc. AKYA: This life-sciences technology company has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 10.4% over the last 60 days.
Akoya Biosciences, Inc. Price and Consensus
Akoya Biosciences, Inc. price-consensus-chart | Akoya Biosciences, Inc. Quote
Akoya’s shares gained 11.9% over the last three months compared with the S&P 500’s advance of 8%. The company possesses a Momentum Score of A.
Akoya Biosciences, Inc. Price
Akoya Biosciences, Inc. price | Akoya Biosciences, Inc. Quote
Alpha Tau Medical Ltd. DRTS: This clinical-stage oncology therapeutics company has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 10.2% over the last 60 days.
Alpha Tau Medical Ltd. Price and Consensus
Alpha Tau Medical Ltd. price-consensus-chart | Alpha Tau Medical Ltd. Quote
Alpha Tau’s shares gained 3.6% over the last month compared with the S&P 500’s advance of 1.7%. The company possesses a Momentum Score of B.
Alpha Tau Medical Ltd. Price
Alpha Tau Medical Ltd. price | Alpha Tau Medical Ltd. Quote
Trupanion, Inc. TRUP: This company that engages in the business of medical insurance for cats and dogs has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 5.4% over the last 60 days.
Trupanion, Inc. Price and Consensus
Trupanion, Inc. price-consensus-chart | Trupanion, Inc. Quote
Trupanion’s shares gained 8.7% over the last three months compared with the S&P 500’s advance of 8%. The company possesses a Momentum Score of B.
Trupanion, Inc. Price
Trupanion, Inc. price | Trupanion, Inc. Quote
See the full list of top ranked stocks here
Learn more about the Momentum score and how it is calculated here.
Just Released: Zacks Top 10 Stocks for 2024
Hurry – you can still get in early on our 10 top tickers for 2024. Hand-picked by Zacks Director of Research, Sheraz Mian, this portfolio has been stunningly and consistently successful. From inception in 2012 through November, 2023, the Zacks Top 10 Stocks gained +974.1%, nearly TRIPLING the S&P 500’s +340.1%. Sheraz has combed through 4,400 companies covered by the Zacks Rank and handpicked the best 10 to buy and hold in 2024. You can still be among the first to see these just-released stocks with enormous potential.
Trupanion, Inc. (TRUP) : Free Stock Analysis Report
Akoya Biosciences, Inc. (AKYA) : Free Stock Analysis Report
Alpha Tau Medical Ltd. (DRTS) : Free Stock Analysis Report
To read this article on Zacks.com click here.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
Image and article originally from www.nasdaq.com. Read the original article here.